ANEB
Price
$1.08
Change
-$0.05 (-4.42%)
Updated
Jun 6 closing price
Capitalization
44.37M
100 days until earnings call
RLAY
Price
$3.36
Change
+$0.12 (+3.70%)
Updated
Jun 6 closing price
Capitalization
553.77M
64 days until earnings call
Interact to see
Advertisement

ANEB vs RLAY

Header iconANEB vs RLAY Comparison
Open Charts ANEB vs RLAYBanner chart's image
Anebulo Pharmaceuticals
Price$1.08
Change-$0.05 (-4.42%)
Volume$2.75K
Capitalization44.37M
Relay Therapeutics
Price$3.36
Change+$0.12 (+3.70%)
Volume$1.77M
Capitalization553.77M
ANEB vs RLAY Comparison Chart
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. RLAY commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and RLAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ANEB: $1.08 vs. RLAY: $2.95)
Brand notoriety: ANEB and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 54% vs. RLAY: 59%
Market capitalization -- ANEB: $46.3M vs. RLAY: $553.77M
ANEB [@Biotechnology] is valued at $46.3M. RLAY’s [@Biotechnology] market capitalization is $553.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than ANEB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 7 bullish TA indicator(s).

  • ANEB’s TA Score: 4 bullish, 3 bearish.
  • RLAY’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than ANEB.

Price Growth

ANEB (@Biotechnology) experienced а -3.57% price change this week, while RLAY (@Biotechnology) price change was +3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ANEB is expected to report earnings on Sep 17, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($554M) has a higher market cap than ANEB($44.4M). RLAY YTD gains are higher at: -28.398 vs. ANEB (-35.714). ANEB has higher annual earnings (EBITDA): -7.43M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. ANEB (15M). RLAY has higher revenues than ANEB: RLAY (10M) vs ANEB (0).
ANEBRLAYANEB / RLAY
Capitalization44.4M554M8%
EBITDA-7.43M-380.21M2%
Gain YTD-35.714-28.398126%
P/E RatioN/AN/A-
Revenue010M-
Total Cash15M781M2%
Total DebtN/A48.5M-
TECHNICAL ANALYSIS
Technical Analysis
ANEBRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
83%
Momentum
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 13 days ago
75%
MACD
ODDS (%)
Bullish Trend 13 days ago
90%
Bearish Trend 13 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
83%
Bearish Trend 13 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 28 days ago
87%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 14 days ago
79%
Bullish Trend 13 days ago
85%
Aroon
ODDS (%)
Bullish Trend 13 days ago
88%
Bullish Trend 13 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-4.42%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
+0.91%
SRPT - ANEB
24%
Poorly correlated
-2.92%
RLAY - ANEB
23%
Poorly correlated
+3.51%
IMUC - ANEB
23%
Poorly correlated
-16.68%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+3.51%
XNCR - RLAY
50%
Loosely correlated
-2.58%
BCYC - RLAY
49%
Loosely correlated
+2.12%
KYMR - RLAY
46%
Loosely correlated
+2.35%
IMNM - RLAY
46%
Loosely correlated
+0.35%
RXRX - RLAY
45%
Loosely correlated
+0.11%
More